1. Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis

   • Zhengbo Song
   • Baochai Lin
   • Yiping Zhang

   Original Paper 13 May 2012 Pages: 1613 - 1617

   

2. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α)

   • Chuanyang Sun
   • Hui Song
   • Liang Zhang

   Original Paper 22 May 2012 Pages: 1619 - 1624

   

3. Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer

   • Eun Kyoung Jeon
   • Hye-Sung Won
   • Myung Ah Lee

   Original Paper 22 May 2012 Pages: 1625 - 1630

   

4. Prognostic value of tumor progression-related gene expression in colorectal cancer patients

   • Miriam E. Uhlmann
   • Milka Georgieva
   • Martin R. Berger

   Original Paper 22 May 2012 Pages: 1631 - 1640

   

5. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

   • Yong-Kui Zhang
   • Wang-Yu Zhu
   • Xiao-Guang Liu

   Original Paper 22 May 2012 Pages: 1641 - 1650

   

6. Fusion between tumor cells enhances melanoma metastatic potential

   • Ruifang Mi
   • Chunxiao Pan
   • Jianhui Ma

   Original Paper 24 May 2012 Pages: 1651 - 1658

   

7. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors

   • Bing Wang
   • Qingyun Zhang

   Original Paper 26 May 2012 Pages: 1659 - 1666

   

8. The identification of significant chromosomal regions correlated with oral tongue cancer progression

   • Ki-Yeol Kim
   • In-Ho Cha

   Original Paper 26 May 2012 Pages: 1667 - 1677

   

9. Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study

   • Murat Zor
   • Ibrahim Yildirim
   • Murat Dayanc

   Original Paper 26 May 2012 Pages: 1679 - 1682

   

10. Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival

    • Matt Williams
    • Zi Wei Liu
    • Elena Wilson

    Original Paper 27 May 2012 Pages: 1683 - 1688

    

11. XPD Asp312Asn polymorphism is a risk factor for prostate cancer

    • Shao-Guang Liao
    • Lu Liu
    • Ya-Jie Wang

    Original Paper 29 May 2012 Pages: 1689 - 1695

    

12. Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma

    • Marta Hegyi
    • Ágnes Gulácsi
    • Gábor T. Kovács

    Original Paper 01 June 2012 Pages: 1697 - 1702

    

13. N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer

    • Xiu-Hong Lv
    • Jia-Wei Chen
    • Guang-Hui Zhu

    Original Paper 08 June 2012 Pages: 1703 - 1715

    

14. Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

    • Ying Jin
    • Xiu-Yu Cai
    • Wen-Qi Jiang

    Original Paper 10 June 2012 Pages: 1717 - 1725

    

15. Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production

    • Guangying Du
    • Liang Ye
    • Jingwei Tian

    Original Paper 15 June 2012 Pages: 1727 - 1736

    

16. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?

    • Linlin Liu
    • Nian Liu
    • Jun Wei

    Original Paper 15 June 2012 Pages: 1737 - 1742

    

17. Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB

    • Moon Hee Yang
    • Kyu Taek Lee
    • Jong Chul Rhee

    Original Paper 15 June 2012 Pages: 1743 - 1751

    

18. HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents

    • Emmanuelle Tavernier
    • Pascale Flandrin-Gresta
    • Lydia Campos

    Original Paper 17 June 2012 Pages: 1753 - 1758

    

19. Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer

    • Yaming Du
    • Leizhi Shi
    • Zhongbin Wang

    Original Paper 20 June 2012 Pages: 1759 - 1767

    

20. Expression and biological role of δ-catenin in human ovarian cancer

    • Yuanyuan Fang
    • Zhengtao Li
    • Shulan Zhang

    Original Paper 15 June 2012 Pages: 1769 - 1776

    

21. Erratum to: Expression and biological role of δ-catenin in human ovarian cancer

    • Yuanyuan Fang
    • Zhengtao Li
    • Shulan Zhang

    Erratum 06 September 2012 Pages: 1777 - 1777

22. RETRACTED ARTICLE: Radioembolization using Yttrium-90 microspheres in 58 patients with liver metastases from breast cancer

    • Changming Shen
    • Xueling Yang
    • Qiang Li

    Original Paper 22 June 2012 Pages: 1779 - 1779

23. miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer

    • Zhiwei Zhong
    • Zhuo Dong
    • Zhaohui Gong

    Rapid Communication 18 July 2012 Pages: 1781 - 1788